Selected article for: "antigen presentation and strong immune response"

Author: Harrell, Carl Randall; Popovska Jovicic, Biljana; Djonov, Valentin; Volarevic, Vladislav
Title: Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases
  • Cord-id: 9wbxr6jh
  • Document date: 2021_4_1
  • ID: 9wbxr6jh
    Snippet: Mesenchymal stem cells (MSCs) are adult, immunomodulatory stem cells which reside in almost all postnatal tissues. Viral antigens and damage-associated molecular patterns released from injured and infected cells activate MSCs, which elicit strong antiviral immune response. MSC-sourced interferons and inflammatory cytokines modulate the cytotoxicity of NK cells and CTLs, enhance the antigen-presentation properties of DCs and macrophages, regulate cytokine synthesis in CD4+ T helper cells and prom
    Document: Mesenchymal stem cells (MSCs) are adult, immunomodulatory stem cells which reside in almost all postnatal tissues. Viral antigens and damage-associated molecular patterns released from injured and infected cells activate MSCs, which elicit strong antiviral immune response. MSC-sourced interferons and inflammatory cytokines modulate the cytotoxicity of NK cells and CTLs, enhance the antigen-presentation properties of DCs and macrophages, regulate cytokine synthesis in CD4+ T helper cells and promote antibody production in B cells. After the elimination of viral pathogens, MSCs produce immunoregulatory cytokines and trophic factors, prevent the over-activation of immune cells and promote tissue repair and regeneration. In this review article, we summarize the current knowledge on the molecular mechanisms that are responsible for the MSC-dependent elimination of virus-infected cells, and we emphasize the therapeutic potential of MSCs and their secretomes in the treatment of viral diseases.

    Search related documents:
    Co phrase search for related documents
    • abdominal distension and liver disease: 1
    • abdominal distension and liver failure: 1
    • abdominal distension and liver function: 1, 2
    • aclf chronic liver failure acute and acute liver hepatitis failure: 1, 2, 3
    • aclf chronic liver failure acute and acute sars respiratory syndrome coronavirus: 1
    • aclf chronic liver failure and acute liver hepatitis failure: 1, 2, 3
    • aclf chronic liver failure and acute sars respiratory syndrome coronavirus: 1
    • aclf chronic liver failure and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • aclf chronic liver failure and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • aclf chronic liver failure and liver function: 1, 2, 3
    • aclf chronic liver failure and liver hepatitis: 1, 2, 3, 4, 5
    • aclf chronic liver failure and liver hepatitis failure: 1, 2, 3